Atypical Antipsychotic [EPC]

Atypical Antipsychotic [EPC] was reported 450588 times

Drugs of the Atypical Antipsychotic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NEUTROPHIL COUNT NORMAL 335 0.9738
1 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1526 0.9014
2 ANTIPSYCHOTIC DRUG LEVEL DECREASED 478 0.9002
3 BANKRUPTCY 390 0.8667
4 HYPERPROLACTINAEMIA 5237 0.8071
5 GYNAECOMASTIA 24988 0.8069
6 BLOOD PROLACTIN ABNORMAL 692 0.8019
7 ABNORMAL WEIGHT GAIN 9817 0.7939
8 COMPULSIVE SEXUAL BEHAVIOUR 640 0.7901
9 GAMBLING DISORDER 2113 0.7814
10 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 530 0.7670
11 ANOSOGNOSIA 576 0.7500
12 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2021 0.7172
13 SCHIZOAFFECTIVE DISORDER 1229 0.6885
14 GALACTORRHOEA 4381 0.6813
15 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 592 0.6652
16 SCHIZOPHRENIA 8059 0.6625
17 DIVORCED 290 0.6576
18 HOMELESS 289 0.6494
19 NEUROLEPTIC MALIGNANT SYNDROME 7646 0.6440
20 COMPULSIVE SHOPPING 1258 0.6110
21 PSYCHIATRIC DECOMPENSATION 1169 0.5976
22 PLEUROTHOTONUS 530 0.5863
23 OCULOGYRIC CRISIS 1205 0.5610
24 PSYCHOTIC SYMPTOM 1133 0.5484
25 COGWHEEL RIGIDITY 574 0.5467
26 BLOOD PROLACTIN INCREASED 2467 0.5227
27 GRANULOCYTOPENIA 2828 0.4960
28 GAMBLING 571 0.4897
29 CATATONIA 2562 0.4874
30 EOSINOPHIL COUNT DECREASED 1153 0.4838
31 NEUTROPHILIA 2751 0.4831
32 AKATHISIA 6584 0.4820
33 METABOLIC SYNDROME 779 0.4738
34 DIABETES MELLITUS NON-INSULIN-DEPENDENT 655 0.4502
35 NEUTROPHIL COUNT INCREASED 4463 0.4354
36 POST-INJECTION DELIRIUM SEDATION SYNDROME 359 0.4160
37 OROMANDIBULAR DYSTONIA 288 0.3951
38 PARKINSONISM 3692 0.3783
39 OBESITY 5828 0.3654
40 ANTICHOLINERGIC SYNDROME 575 0.3607
41 OBSESSIVE-COMPULSIVE DISORDER 2743 0.3415
42 PERSECUTORY DELUSION 852 0.3413
43 PSYCHOTIC DISORDER 9794 0.3313
44 SALIVARY HYPERSECRETION 3294 0.3289
45 HYPERSEXUALITY 597 0.3264
46 HALLUCINATION, AUDITORY 5188 0.3262
47 SEDATION COMPLICATION 788 0.3085
48 HYPOMANIA 1109 0.3013
49 DISINHIBITION 484 0.3004
50 SEDATION 7872 0.3003
51 SELF INJURIOUS BEHAVIOUR 899 0.2944
52 DIABETIC COMA 807 0.2879
53 REDUCED FACIAL EXPRESSION 289 0.2847
54 DISTURBANCE IN SOCIAL BEHAVIOUR 667 0.2829
55 PRIAPISM 975 0.2824
56 SOPOR 3735 0.2816
57 EXTRAPYRAMIDAL DISORDER 6912 0.2781
58 MANIA 4555 0.2766
59 MEAN CELL HAEMOGLOBIN DECREASED 498 0.2718
60 DELUSION 4227 0.2718
61 METABOLIC DISORDER 1578 0.2715
62 MUTISM 389 0.2677
63 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 440 0.2636
64 PSYCHOMOTOR RETARDATION 724 0.2574
65 GESTATIONAL DIABETES 1193 0.2501
66 DEEP VEIN THROMBOSIS POSTOPERATIVE 500 0.2496
67 BINGE EATING 269 0.2493
68 MUSCLE RIGIDITY 2984 0.2493
69 EMOTIONAL POVERTY 437 0.2491
70 MEAN CELL VOLUME DECREASED 383 0.2482
71 DROOLING 1713 0.2477
72 IMPULSE-CONTROL DISORDER 510 0.2476
73 BEZOAR 341 0.2471
74 DYSTONIA 4749 0.2446
75 TORTICOLLIS 519 0.2446
76 TARDIVE DYSKINESIA 6868 0.2432
77 ACUTE PSYCHOSIS 599 0.2419
78 BIPOLAR I DISORDER 512 0.2332
79 MYOCARDITIS 2673 0.2330
80 IMPULSIVE BEHAVIOUR 873 0.2324
81 INTENTIONAL SELF-INJURY 4661 0.2305
82 LIVING IN RESIDENTIAL INSTITUTION 430 0.2291
83 MONOCYTE COUNT INCREASED 819 0.2253
84 EMOTIONAL DISORDER 6932 0.2246
85 WRONG PATIENT RECEIVED PRODUCT 643 0.2195
86 PSYCHOMOTOR SKILLS IMPAIRED 574 0.2189
87 IMPRISONMENT 381 0.2154
88 HYPERAMMONAEMIC ENCEPHALOPATHY 368 0.2115
89 STUPOR 668 0.2077
90 POLYDIPSIA 799 0.2019
91 LOSS OF EMPLOYMENT 595 0.1968
92 PARANOIA 3387 0.1963
93 BIPOLAR DISORDER 2109 0.1938
94 MEGACOLON 304 0.1934
95 HALLUCINATIONS, MIXED 808 0.1919
96 OBSESSIVE THOUGHTS 346 0.1918
97 BREAST DISCHARGE 330 0.1881
98 COMA SCALE ABNORMAL 545 0.1879
99 BREAST ENLARGEMENT 605 0.1845
100 SWOLLEN JOINT COUNT INCREASED 586 0.1836
101 BRADYKINESIA 1083 0.1833
102 SUICIDE ATTEMPT 11104 0.1830
103 LIBIDO INCREASED 371 0.1828
104 ELECTROCARDIOGRAM QT PROLONGED 6522 0.1811
105 GAZE PALSY 308 0.1806
106 HYPERPHAGIA 713 0.1786
107 HYPOTONIA NEONATAL 279 0.1785
108 SEROTONIN SYNDROME 3428 0.1783
109 DEPRESSIVE SYMPTOM 626 0.1774
110 POSTURE ABNORMAL 575 0.1766
111 RESPIRATORY DISORDER NEONATAL 286 0.1763
112 ENURESIS 712 0.1761
113 FLAT AFFECT 403 0.1739
114 POISONING DELIBERATE 1642 0.1730
115 OVERWEIGHT 930 0.1730
116 HYPOTHERMIA 1742 0.1719
117 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 356 0.1716
118 TIC 937 0.1716
119 SUSPECTED SUICIDE 784 0.1671
120 LYMPHOCYTE COUNT INCREASED 543 0.1662
121 TROPONIN INCREASED 1263 0.1658
122 DYSKINESIA 6688 0.1644
123 MENTAL IMPAIRMENT 3983 0.1642
124 HYPERKINESIA 348 0.1640
125 ACCIDENTAL DEATH 305 0.1640
126 FAECALOMA 896 0.1634
127 LOGORRHOEA 567 0.1608
128 PERSONALITY DISORDER 417 0.1590
129 MIOSIS 1274 0.1586
130 NEUTROPENIA 21499 0.1580
131 TREATMENT NONCOMPLIANCE 8624 0.1575
132 SINUS TACHYCARDIA 2233 0.1571
133 HOMICIDAL IDEATION 635 0.1565
134 SEXUAL DYSFUNCTION 1836 0.1564
135 PSYCHIATRIC SYMPTOM 1130 0.1530
136 AGGRESSION 7628 0.1523
137 BEHAVIOUR DISORDER 822 0.1518
138 TACHYPHRENIA 526 0.1517
139 STARING 367 0.1517
140 RESTLESSNESS 5527 0.1509
141 INTENTIONAL OVERDOSE 9658 0.1504
142 SOCIAL AVOIDANT BEHAVIOUR 869 0.1500
143 HOSTILITY 381 0.1498
144 ALCOHOL ABUSE 398 0.1487
145 AGRANULOCYTOSIS 2762 0.1485
146 HYPERREFLEXIA 515 0.1477
147 BRADYPHRENIA 963 0.1473
148 WHITE BLOOD CELL COUNT INCREASED 5647 0.1470
149 RHEUMATIC FEVER 645 0.1446
150 TYPE 2 DIABETES MELLITUS 4787 0.1420
151 LEUKOCYTOSIS 2564 0.1415
152 DELIRIUM 4904 0.1412
153 RED CELL DISTRIBUTION WIDTH INCREASED 587 0.1411
154 MULTIPLE DRUG OVERDOSE INTENTIONAL 451 0.1401
155 AKINESIA 288 0.1389
156 HYPERTHERMIA 1053 0.1378
157 SUICIDAL BEHAVIOUR 573 0.1376
158 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 306 0.1367
159 SELF-INJURIOUS IDEATION 573 0.1364
160 ILEUS PARALYTIC 607 0.1359
161 AUTONOMIC NERVOUS SYSTEM IMBALANCE 397 0.1358
162 PRESCRIBED OVERDOSE 2599 0.1342
163 TYPE 1 DIABETES MELLITUS 808 0.1340
164 DIABETIC NEUROPATHY 663 0.1338
165 MEAN CELL VOLUME INCREASED 343 0.1335
166 PNEUMONIA ASPIRATION 3319 0.1327
167 AGITATION 9743 0.1325
168 COMPLETED SUICIDE 11053 0.1325
169 DEREALISATION 285 0.1324
170 ELECTROENCEPHALOGRAM ABNORMAL 417 0.1319
171 BLOOD CREATINE PHOSPHOKINASE INCREASED 3779 0.1311
172 SUBSTANCE USE DISORDER 418 0.1311
173 IMPAIRED SELF-CARE 270 0.1302
174 DISLOCATION OF VERTEBRA 297 0.1301
175 PHYSICAL ASSAULT 270 0.1291
176 LONG QT SYNDROME 309 0.1288
177 BLOOD TRIGLYCERIDES INCREASED 2274 0.1286
178 GASTROINTESTINAL HYPOMOTILITY 290 0.1285
179 MAJOR DEPRESSION 939 0.1284
180 ABNORMAL BEHAVIOUR 5085 0.1282
181 TONGUE BITING 263 0.1274
182 COMA 5982 0.1255
183 DRUG LEVEL INCREASED 2078 0.1254
184 TRISMUS 647 0.1252
185 INCREASED APPETITE 2390 0.1250
186 PSYCHOMOTOR HYPERACTIVITY 2062 0.1241
187 CLONUS 339 0.1238
188 DEPRESSED LEVEL OF CONSCIOUSNESS 4871 0.1230
189 BRADYPNOEA 331 0.1225
190 BRUXISM 656 0.1215
191 BUNDLE BRANCH BLOCK RIGHT 557 0.1212
192 ECONOMIC PROBLEM 1827 0.1204
193 ON AND OFF PHENOMENON 668 0.1202
194 DIABETES MELLITUS 9109 0.1194
195 SUICIDAL IDEATION 10915 0.1191
196 COMMUNICATION DISORDER 453 0.1183
197 HYPERNATRAEMIA 590 0.1183
198 SLOW SPEECH 287 0.1181
199 TEMPERATURE REGULATION DISORDER 263 0.1179
200 RESPIRATORY DEPRESSION 1444 0.1177
201 APATHY 1718 0.1177
202 POTENTIATING DRUG INTERACTION 395 0.1176
203 MYOCLONUS 1402 0.1174
204 RHEUMATOID FACTOR POSITIVE 675 0.1167
205 DYSLIPIDAEMIA 592 0.1164
206 SUDDEN CARDIAC DEATH 396 0.1160
207 ALTERED STATE OF CONSCIOUSNESS 2491 0.1149
208 EOSINOPHIL COUNT INCREASED 952 0.1141
209 MENTAL DISORDER 4965 0.1140
210 GLUCOSE TOLERANCE IMPAIRED 671 0.1133
211 FREEZING PHENOMENON 420 0.1133
212 HALLUCINATION, VISUAL 2388 0.1130
213 REFUSAL OF TREATMENT BY PATIENT 736 0.1126
214 AFFECTIVE DISORDER 884 0.1123
215 DIABETIC COMPLICATION 286 0.1122
216 INJURY 7887 0.1121
217 WEIGHT INCREASED 25124 0.1121
218 HYPERTONIA 639 0.1115
219 ORTHOSTATIC HYPOTENSION 1938 0.1112
220 THINKING ABNORMAL 2070 0.1110
221 DRUG INTERACTION 17575 0.1107
222 POISONING 1388 0.1104
223 EYE MOVEMENT DISORDER 755 0.1102
224 ELECTROCARDIOGRAM ABNORMAL 858 0.1092
225 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 559 0.1089
226 PARKINSON'S DISEASE 277 0.1089
227 SUDDEN DEATH 1149 0.1085
228 HYPERTRIGLYCERIDAEMIA 629 0.1073
229 FACET JOINT SYNDROME 349 0.1071
230 HYPERAMMONAEMIA 533 0.1065
231 EMBOLISM VENOUS 323 0.1064
232 HOSPITALISATION 16300 0.1060
233 ALCOHOL POISONING 281 0.1048
234 ASPIRATION 1135 0.1035
235 BRAIN INJURY 1038 0.1034
236 RHABDOMYOLYSIS 4216 0.1010
237 SUBSTANCE ABUSE 822 0.1009
238 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1033 0.1005
239 DYSARTHRIA 3771 0.1001
240 BLOOD CHOLESTEROL ABNORMAL 461 0.0997
241 DUODENAL ULCER PERFORATION 738 0.0991
242 PARADOXICAL DRUG REACTION 364 0.0988
243 HALLUCINATION 7406 0.0982
244 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 704 0.0982
245 NEUTROPHIL COUNT DECREASED 3993 0.0979
246 DRUG ABUSE 8133 0.0976
247 TOXICITY TO VARIOUS AGENTS 16473 0.0976
248 DYSPHEMIA 427 0.0973
249 HYPERLIPIDAEMIA 1155 0.0966
250 PERIPHERAL VENOUS DISEASE 393 0.0961
251 STOMA SITE DISCHARGE 263 0.0960
252 HIGH DENSITY LIPOPROTEIN DECREASED 320 0.0960
253 TACHYCARDIA 8456 0.0951
254 PERSONALITY CHANGE 880 0.0946
255 MULTIPLE DRUG OVERDOSE 469 0.0944
256 PLATELET COUNT INCREASED 1199 0.0919
257 CONGESTIVE CARDIOMYOPATHY 383 0.0918
258 COLITIS ISCHAEMIC 619 0.0917
259 SOMNAMBULISM 601 0.0915
260 CEREBRAL ATROPHY 362 0.0907
261 SCREAMING 572 0.0897
262 TORSADE DE POINTES 703 0.0895
263 TEARFULNESS 383 0.0890
264 HYPERGLYCAEMIA 3228 0.0885
265 LEUKOPENIA 4378 0.0874
266 ATRIOVENTRICULAR BLOCK FIRST DEGREE 377 0.0869
267 LEFT VENTRICULAR HYPERTROPHY 371 0.0866
268 SOMNOLENCE 17453 0.0866
269 MUSCLE TWITCHING 1993 0.0864
270 GENERALISED TONIC-CLONIC SEIZURE 1428 0.0862
271 PERICARDITIS 1449 0.0862
272 MYDRIASIS 1100 0.0857
273 INCONTINENCE 906 0.0856
274 EUPHORIC MOOD 878 0.0856
275 DEPRESSION SUICIDAL 296 0.0854
276 HYPERCHOLESTEROLAEMIA 825 0.0854
277 DIABETIC KETOACIDOSIS 2050 0.0853
278 HAEMATOCRIT DECREASED 1675 0.0844
279 ATAXIA 999 0.0841
280 C-REACTIVE PROTEIN ABNORMAL 537 0.0836
281 BLEPHAROSPASM 527 0.0836
282 RESTLESS LEGS SYNDROME 1519 0.0834
283 PEMPHIGUS 1044 0.0834
284 MUSCLE INJURY 691 0.0833
285 INCOHERENT 539 0.0832
286 SMALL FOR DATES BABY 413 0.0831
287 TENSION 506 0.0830
288 JAUNDICE CHOLESTATIC 292 0.0826
289 UNRESPONSIVE TO STIMULI 2113 0.0818
290 EOSINOPHILIA 1429 0.0815
291 URINARY INCONTINENCE 2410 0.0813
292 FOOD CRAVING 428 0.0812
293 POST-TRAUMATIC STRESS DISORDER 544 0.0811
294 VENTRICULAR ARRHYTHMIA 293 0.0800
295 SINUS BRADYCARDIA 770 0.0796
296 DRUG USE DISORDER 665 0.0790
297 EATING DISORDER 1670 0.0783
298 LIVE BIRTH 655 0.0782
299 BLOOD CHOLESTEROL INCREASED 3637 0.0779
300 C-REACTIVE PROTEIN INCREASED 2837 0.0779
301 DRUG LEVEL ABOVE THERAPEUTIC 357 0.0779
302 POLYURIA 634 0.0773
303 LEFT VENTRICULAR DYSFUNCTION 518 0.0773
304 SOCIAL PROBLEM 317 0.0765
305 URINARY RETENTION 2545 0.0762
306 MENTAL STATUS CHANGES 2116 0.0761
307 DISORIENTATION 3015 0.0760
308 HYPOTONIA 754 0.0755
309 DISSOCIATION 579 0.0754
310 HYPERSOMNIA 2145 0.0747
311 SLUGGISHNESS 763 0.0747
312 CIRCULATORY COLLAPSE 1263 0.0741
313 ALCOHOLISM 316 0.0737
314 THROMBOCYTOSIS 268 0.0731
315 CARDIO-RESPIRATORY ARREST 3045 0.0727
316 DYSPHORIA 366 0.0722
317 COGNITIVE DISORDER 3376 0.0722
318 HELICOBACTER INFECTION 742 0.0721
319 SNORING 271 0.0716
320 CONFUSIONAL STATE 11544 0.0714
321 HAEMOGLOBIN INCREASED 325 0.0712
322 TREMOR 11825 0.0712
323 PANIC DISORDER 275 0.0709
324 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 459 0.0706
325 ANGER 2387 0.0705
326 AFFECT LABILITY 679 0.0705
327 GRAND MAL CONVULSION 651 0.0704
328 BUNDLE BRANCH BLOCK LEFT 297 0.0700
329 HAND DEFORMITY 917 0.0698
330 WRONG PRODUCT ADMINISTERED 471 0.0696
331 FEELING OF DESPAIR 323 0.0692
332 HYPOKINESIA 1004 0.0691
333 DISTURBANCE IN ATTENTION 3713 0.0688
334 DRUG TOXICITY 935 0.0686
335 TOXIC ENCEPHALOPATHY 343 0.0676
336 LIVER INJURY 1659 0.0675
337 DISABILITY 1335 0.0674
338 DEMENTIA 1877 0.0671
339 GENERAL PHYSICAL CONDITION ABNORMAL 454 0.0669
340 HAEMODYNAMIC INSTABILITY 508 0.0666
341 FOLLICULITIS 697 0.0664
342 HYPONATRAEMIA 3720 0.0660
343 NYSTAGMUS 349 0.0657
344 AUTISM SPECTRUM DISORDER 361 0.0655
345 SPEECH DISORDER 3420 0.0652
346 AUTOIMMUNE DISORDER 636 0.0652
347 RESPIRATORY ARREST 1786 0.0647
348 ARTERIOSCLEROSIS CORONARY ARTERY 426 0.0642
349 CARDIOMYOPATHY 949 0.0641
350 IRRITABILITY 3859 0.0641
351 LYMPHOCYTE COUNT DECREASED 1131 0.0639
352 WITHDRAWAL SYNDROME 2675 0.0636
353 VENTRICULAR SEPTAL DEFECT 363 0.0633
354 ASPHYXIA 514 0.0629
355 PANCREATITIS 3310 0.0626
356 EPILEPSY 1909 0.0624
357 DECREASED INTEREST 368 0.0623
358 ILEUS 769 0.0618
359 MOTOR DYSFUNCTION 628 0.0616
360 AMENORRHOEA 1073 0.0611
361 HEPATIC STEATOSIS 1135 0.0609
362 STATUS EPILEPTICUS 688 0.0609
363 TACHYPNOEA 828 0.0608
364 ATRIAL SEPTAL DEFECT 509 0.0607
365 INABILITY TO AFFORD MEDICATION 602 0.0606
366 INTESTINAL ISCHAEMIA 333 0.0604
367 FAECAL INCONTINENCE 288 0.0599
368 BLOOD LACTIC ACID INCREASED 314 0.0595
369 BODY TEMPERATURE INCREASED 1210 0.0592
370 SLEEP APNOEA SYNDROME 1119 0.0586
371 HEPATIC CYTOLYSIS 745 0.0584
372 PETIT MAL EPILEPSY 296 0.0579
373 WHITE BLOOD CELL COUNT DECREASED 6268 0.0578
374 PRODUCT USE IN UNAPPROVED INDICATION 14302 0.0576
375 DRUG SCREEN POSITIVE 454 0.0574
376 ERECTILE DYSFUNCTION 1468 0.0571
377 RED BLOOD CELL COUNT DECREASED 1634 0.0571
378 CONTRAINDICATED PRODUCT ADMINISTERED 1727 0.0570
379 ENCEPHALOPATHY 1397 0.0568
380 TONGUE DISORDER 409 0.0565
381 APLASTIC ANAEMIA 294 0.0562
382 MEDICATION ERROR 3125 0.0562
383 KETOACIDOSIS 418 0.0558
384 LIP DRY 507 0.0558
385 PRESCRIBED UNDERDOSE 1112 0.0557
386 DIABETES MELLITUS INADEQUATE CONTROL 986 0.0556
387 APNOEA 429 0.0550
388 LOWER RESPIRATORY TRACT INFECTION 2501 0.0549
389 NORMAL NEWBORN 298 0.0548
390 DEPRESSED MOOD 2879 0.0544
391 DEPRESSION 12296 0.0540
392 FLUID INTAKE REDUCED 270 0.0539
393 FOETAL EXPOSURE DURING PREGNANCY 4341 0.0533
394 TERMINAL STATE 353 0.0527
395 WOUND 1474 0.0527
396 ANHEDONIA 1384 0.0526
397 ANXIETY 14909 0.0523
398 SEIZURE 6030 0.0522
399 CARDIAC ARREST 4308 0.0521
400 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1154 0.0520
401 CONVULSION 2974 0.0520
402 NEUROLOGICAL SYMPTOM 297 0.0519
403 HEPATOCELLULAR INJURY 732 0.0516
404 OVERDOSE 11124 0.0515
405 DRUG LEVEL BELOW THERAPEUTIC 283 0.0512
406 LETHARGY 2949 0.0512
407 COORDINATION ABNORMAL 714 0.0511
408 INITIAL INSOMNIA 525 0.0511
409 HUNGER 709 0.0508
410 MOVEMENT DISORDER 1634 0.0508
411 ENERGY INCREASED 300 0.0508
412 GRIP STRENGTH DECREASED 447 0.0507
413 GLOSSODYNIA 1135 0.0506
414 PANIC ATTACK 1847 0.0506
415 FIBROMYALGIA 1223 0.0503
416 DRUG LEVEL DECREASED 508 0.0499
417 DECUBITUS ULCER 404 0.0495
418 CHOKING 966 0.0495
419 HYPERVENTILATION 286 0.0493
420 SLEEP DISORDER 3471 0.0491
421 METABOLIC ACIDOSIS 1568 0.0490
422 LOSS OF CONSCIOUSNESS 6274 0.0489
423 PANCREATITIS ACUTE 1098 0.0488
424 ACIDOSIS 373 0.0488
425 APPETITE DISORDER 322 0.0485
426 ANAL INCONTINENCE 436 0.0484
427 THERAPY CESSATION 2484 0.0483
428 CAESAREAN SECTION 563 0.0483
429 PANIC REACTION 349 0.0483
430 RED BLOOD CELL SEDIMENTATION RATE INCREASED 535 0.0483
431 MUSCULOSKELETAL STIFFNESS 4230 0.0482
432 NIGHTMARE 1668 0.0482
433 BLOOD SODIUM DECREASED 907 0.0481
434 FEAR 1294 0.0481
435 DYSPHAGIA 4561 0.0480
436 PRODUCT ADMINISTRATION INTERRUPTED 377 0.0480
437 BRAIN OEDEMA 606 0.0479
438 APHASIA 1443 0.0477
439 GENERAL PHYSICAL HEALTH DETERIORATION 5528 0.0477
440 THERMAL BURN 339 0.0477
441 BRADYCARDIA 2528 0.0476
442 BLOOD ALBUMIN DECREASED 378 0.0476
443 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 341 0.0475
444 PRE-EXISTING CONDITION IMPROVED 297 0.0475
445 CARDIOMEGALY 584 0.0474
446 MOOD ALTERED 1292 0.0473
447 POOR QUALITY SLEEP 1015 0.0471
448 EMOTIONAL DISTRESS 5698 0.0470
449 THIRST 840 0.0470
450 SYNOVITIS 842 0.0467
451 TRICUSPID VALVE INCOMPETENCE 371 0.0466
452 VENTRICULAR EXTRASYSTOLES 484 0.0466
453 BURSITIS 564 0.0464
454 AMNESIA 3012 0.0463
455 MATERNAL EXPOSURE DURING PREGNANCY 4097 0.0459
456 MOOD SWINGS 1464 0.0459
457 LOSS OF LIBIDO 413 0.0459
458 HICCUPS 376 0.0458
459 INSOMNIA 12114 0.0454
460 BLOOD ALKALINE PHOSPHATASE INCREASED 1129 0.0454
461 MYOCARDIAL ISCHAEMIA 516 0.0453
462 CRYING 1644 0.0452
463 HYPOPHAGIA 1152 0.0450
464 ELECTROLYTE IMBALANCE 523 0.0450
465 LIVER FUNCTION TEST ABNORMAL 1301 0.0447
466 VENTRICULAR FIBRILLATION 496 0.0446
467 IRRITABLE BOWEL SYNDROME 954 0.0444
468 CARDIAC MURMUR 382 0.0441
469 PULMONARY EMBOLISM 4182 0.0440
470 WOUND INFECTION 481 0.0439
471 HYPOTENSION 8811 0.0439
472 HAEMOGLOBIN DECREASED 4508 0.0439
473 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 297 0.0436
474 FEELING DRUNK 323 0.0434
475 LOWER LIMB FRACTURE 835 0.0434
476 CYANOSIS 683 0.0434
477 INFARCTION 297 0.0434
478 HYPOKALAEMIA 1993 0.0431
479 SCIATICA 688 0.0431
480 EXPOSURE DURING PREGNANCY 2679 0.0431
481 SHOCK 986 0.0428
482 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 379 0.0428
483 UROSEPSIS 395 0.0428
484 CARDIOGENIC SHOCK 610 0.0425
485 WALKING AID USER 280 0.0424
486 BREAST CANCER STAGE III 274 0.0423
487 IRON DEFICIENCY ANAEMIA 388 0.0420
488 ALANINE AMINOTRANSFERASE INCREASED 2580 0.0420
489 FORMICATION 291 0.0418
490 SUPRAVENTRICULAR TACHYCARDIA 400 0.0417
491 HYPOGLYCAEMIA 2026 0.0417
492 ADVERSE EVENT 3819 0.0414
493 INTESTINAL OBSTRUCTION 1562 0.0414
494 VENTRICULAR TACHYCARDIA 684 0.0414
495 INSURANCE ISSUE 631 0.0412
496 ARRHYTHMIA 1942 0.0410
497 ACCIDENTAL OVERDOSE 1497 0.0409
498 HYPOXIA 1437 0.0408
499 DRUG WITHDRAWAL SYNDROME NEONATAL 603 0.0407
500 HEPATITIS C 491 0.0406
501 SMALL INTESTINAL OBSTRUCTION 499 0.0405
502 JOINT DISLOCATION 428 0.0404
503 HYPOTHYROIDISM 1292 0.0404
504 CEREBRAL DISORDER 299 0.0404
505 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1033 0.0401
506 LOW DENSITY LIPOPROTEIN INCREASED 307 0.0396
507 DECREASED ACTIVITY 427 0.0395
508 HEAD INJURY 1251 0.0395
509 RESPIRATORY DISTRESS 1091 0.0395
510 MITRAL VALVE INCOMPETENCE 447 0.0395
511 JOINT RANGE OF MOTION DECREASED 529 0.0394
512 RESPIRATORY RATE INCREASED 350 0.0394
513 PRODUCT ADMINISTRATION ERROR 791 0.0391
514 FACIAL PARALYSIS 333 0.0390
515 MUSCLE TIGHTNESS 631 0.0389
516 BLOOD UREA INCREASED 652 0.0389
517 FULL BLOOD COUNT ABNORMAL 409 0.0386
518 PREGNANCY 774 0.0386
519 ACUTE RESPIRATORY FAILURE 742 0.0385
520 HYPERHIDROSIS 4968 0.0385
521 MALNUTRITION 429 0.0383
522 EXTRASYSTOLES 266 0.0381
523 FALL 12633 0.0379
524 OFF LABEL USE 33128 0.0378
525 DRY MOUTH 3067 0.0378
526 BODY TEMPERATURE DECREASED 372 0.0378
527 CARDIOTOXICITY 337 0.0377
528 THERAPY CHANGE 370 0.0376
529 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 643 0.0375
530 ATELECTASIS 362 0.0374
531 ROAD TRAFFIC ACCIDENT 1559 0.0372
532 PULMONARY CONGESTION 488 0.0370
533 IMPAIRED GASTRIC EMPTYING 504 0.0369
534 SYNCOPE 3691 0.0369
535 SYSTEMIC LUPUS ERYTHEMATOSUS 1307 0.0368
536 THROMBOCYTOPENIA 4095 0.0366
537 ASPARTATE AMINOTRANSFERASE INCREASED 1937 0.0364
538 PERICARDIAL EFFUSION 843 0.0364
539 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1744 0.0363
540 CONDITION AGGRAVATED 11017 0.0362
541 CONCUSSION 279 0.0360
542 ACUTE RESPIRATORY DISTRESS SYNDROME 636 0.0359
543 MEMORY IMPAIRMENT 4931 0.0359
544 MENSTRUAL DISORDER 297 0.0358
545 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1867 0.0357
546 BEDRIDDEN 470 0.0357
547 CONGENITAL ANOMALY 276 0.0356
548 GAIT INABILITY 1191 0.0356
549 OEDEMA 1914 0.0353
550 DIZZINESS POSTURAL 342 0.0352
551 EJECTION FRACTION DECREASED 548 0.0352
552 BALANCE DISORDER 3047 0.0352
553 FRUSTRATION TOLERANCE DECREASED 284 0.0351
554 HEPATIC ENZYME INCREASED 2395 0.0351
555 PREMATURE BABY 1057 0.0351
556 PRODUCT USE ISSUE 6599 0.0351
557 PRODUCT PRESCRIBING ERROR 836 0.0351
558 RESPIRATORY FAILURE 2559 0.0351
559 CONSTIPATION 7650 0.0350
560 PARALYSIS 500 0.0349
561 LIPASE INCREASED 267 0.0348
562 EXOSTOSIS 318 0.0348
563 FOOT DEFORMITY 380 0.0342
564 TRANSAMINASES INCREASED 760 0.0341
565 THERAPY INTERRUPTED 2433 0.0340
566 HYPERTENSION 7154 0.0337
567 GAIT DISTURBANCE 6448 0.0337
568 FEELING JITTERY 642 0.0337
569 SWOLLEN TONGUE 1049 0.0336
570 MUSCLE DISORDER 272 0.0336
571 ABNORMAL DREAMS 927 0.0335
572 HEPATOMEGALY 329 0.0334
573 MIDDLE INSOMNIA 624 0.0334
574 PULMONARY FIBROSIS 636 0.0331
575 GLOMERULAR FILTRATION RATE DECREASED 407 0.0331
576 THERAPY NON-RESPONDER 1486 0.0330
577 ACUTE KIDNEY INJURY 5050 0.0330
578 DYSURIA 1214 0.0329
579 INTENTIONAL PRODUCT MISUSE 2882 0.0329
580 HEART RATE INCREASED 3225 0.0325
581 CHOLESTASIS 625 0.0325
582 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1182 0.0325
583 PALLOR 885 0.0325
584 HIP ARTHROPLASTY 497 0.0324
585 RESPIRATORY DISORDER 969 0.0324
586 MOBILITY DECREASED 2323 0.0323
587 VITAMIN D DEFICIENCY 314 0.0322
588 BLOOD LACTATE DEHYDROGENASE INCREASED 510 0.0322
589 DRUG-INDUCED LIVER INJURY 1009 0.0321
590 CHOLELITHIASIS 1048 0.0319
591 DEEP VEIN THROMBOSIS 2062 0.0317
592 HAEMATEMESIS 804 0.0317
593 BLOOD TEST ABNORMAL 443 0.0315
594 DYSSTASIA 915 0.0313
595 HEPATITIS 799 0.0312
596 APPENDICITIS 288 0.0308
597 STEVENS-JOHNSON SYNDROME 683 0.0307
598 BREAST PAIN 327 0.0306
599 PSORIATIC ARTHROPATHY 1239 0.0305
600 NOCTURIA 370 0.0305
601 ACTIVITIES OF DAILY LIVING IMPAIRED 602 0.0304
602 MICTURITION URGENCY 344 0.0301
603 OXYGEN SATURATION DECREASED 1692 0.0301
604 NERVOUSNESS 1571 0.0300
605 MULTIPLE ORGAN DYSFUNCTION SYNDROME 850 0.0300
606 GASTROENTERITIS 435 0.0298
607 HEPATIC CIRRHOSIS 560 0.0298
608 NIGHT SWEATS 960 0.0298
609 BRAIN FOG 466 0.0297
610 WEIGHT FLUCTUATION 310 0.0296
611 HEPATIC ENCEPHALOPATHY 276 0.0295
612 ABORTION INDUCED 278 0.0295
613 FEBRILE NEUTROPENIA 1949 0.0294
614 HEPATIC FUNCTION ABNORMAL 1096 0.0293
615 LIVER DISORDER 1299 0.0293
616 PLATELET COUNT DECREASED 3106 0.0291
617 FEELING ABNORMAL 6983 0.0291
618 GENERALISED OEDEMA 360 0.0291
619 PNEUMONIA 9367 0.0289
620 THERAPY PARTIAL RESPONDER 451 0.0289
621 DENTAL CARIES 318 0.0287
622 PULMONARY OEDEMA 1286 0.0287
623 DEHYDRATION 3824 0.0286
624 ANKLE FRACTURE 443 0.0286
625 NERVOUS SYSTEM DISORDER 893 0.0286
626 CHEST PAIN 5295 0.0286
627 DRUG EXPOSURE DURING PREGNANCY 972 0.0285
628 DRUG RESISTANCE 734 0.0285
629 TREATMENT FAILURE 2364 0.0285
630 SKIN LACERATION 310 0.0285
631 HYPERTENSIVE CRISIS 317 0.0285
632 EMPHYSEMA 287 0.0284
633 OEDEMA PERIPHERAL 3457 0.0283
634 ACUTE HEPATIC FAILURE 387 0.0283
635 ARTERIOSCLEROSIS 266 0.0282
636 BLOOD CREATININE INCREASED 1845 0.0282
637 DISCOMFORT 1721 0.0282
638 SPUTUM DISCOLOURED 267 0.0281
639 DIPLOPIA 731 0.0281
640 VISION BLURRED 3861 0.0281
641 POLLAKIURIA 1172 0.0281
642 PANCYTOPENIA 1569 0.0280
643 ADVERSE DRUG REACTION 2521 0.0280
644 REBOUND EFFECT 316 0.0279
645 URINARY TRACT INFECTION 4764 0.0279
646 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1983 0.0278
647 LEUKAEMIA 263 0.0278
648 OESOPHAGITIS 303 0.0277
649 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1518 0.0276
650 QUALITY OF LIFE DECREASED 370 0.0276
651 PYREXIA 9541 0.0275
652 OBSTRUCTIVE AIRWAYS DISORDER 306 0.0275
653 PREMATURE DELIVERY 438 0.0275
654 IMPAIRED WORK ABILITY 585 0.0273
655 SEPSIS 3052 0.0273
656 IMPAIRED DRIVING ABILITY 311 0.0273
657 BLOOD BILIRUBIN INCREASED 739 0.0273
658 IMPAIRED HEALING 896 0.0273
659 VASCULITIS 317 0.0272
660 VOMITING 12729 0.0270
661 VERTIGO 1647 0.0270
662 BLOOD GLUCOSE ABNORMAL 499 0.0270
663 BLOOD PRESSURE DECREASED 1793 0.0270
664 SENSORY DISTURBANCE 429 0.0267
665 THERAPEUTIC PRODUCT EFFECT DECREASED 1193 0.0266
666 GLYCOSYLATED HAEMOGLOBIN INCREASED 672 0.0266
667 ARTHROPATHY 1477 0.0265
668 OSTEOARTHRITIS 1125 0.0265
669 SPLENOMEGALY 308 0.0263
670 INTENTIONAL DRUG MISUSE 549 0.0262
671 FEEDING DISORDER 532 0.0262
672 RENAL FAILURE ACUTE 1110 0.0261
673 CHOLECYSTITIS 311 0.0261
674 PHARYNGITIS 323 0.0260
675 NEUROTOXICITY 456 0.0260
676 IMPAIRED QUALITY OF LIFE 373 0.0259
677 DRUG INTOLERANCE 2503 0.0259
678 BLOOD PRESSURE FLUCTUATION 620 0.0258
679 LACTIC ACIDOSIS 833 0.0257
680 TOXIC EPIDERMAL NECROLYSIS 390 0.0257
681 DIZZINESS 12766 0.0256
682 WEIGHT DECREASED 7130 0.0255
683 COLD SWEAT 450 0.0255
684 MALAISE 11152 0.0254
685 EAR PAIN 491 0.0252
686 ABORTION SPONTANEOUS 1011 0.0252
687 DEATH 21679 0.0251
688 BLOOD POTASSIUM DECREASED 756 0.0251
689 WHEEZING 1489 0.0251
690 TRANSIENT ISCHAEMIC ATTACK 847 0.0251
691 FACE OEDEMA 423 0.0251
692 SEPTIC SHOCK 1091 0.0250
693 DRUG PRESCRIBING ERROR 480 0.0250
694 RENAL FAILURE 3317 0.0250
695 ANAEMIA 4754 0.0249
696 ANOREXIA 321 0.0249
697 JOINT STIFFNESS 653 0.0249
698 HIATUS HERNIA 321 0.0248
699 RIB FRACTURE 509 0.0247
700 PRODUCT AVAILABILITY ISSUE 563 0.0247
701 PRESYNCOPE 600 0.0247
702 DRUG WITHDRAWAL SYNDROME 2162 0.0246
703 LUNG DISORDER 1207 0.0246
704 FRACTURE 465 0.0245
705 LIVER FUNCTION TEST INCREASED 527 0.0245
706 MUSCULAR WEAKNESS 2781 0.0244
707 PALPITATIONS 2852 0.0243
708 PHOTOPHOBIA 458 0.0243
709 LUNG NEOPLASM MALIGNANT 1000 0.0243
710 LYMPHOPENIA 343 0.0242
711 ACCIDENT 289 0.0242
712 HEART RATE IRREGULAR 543 0.0240
713 DECREASED APPETITE 5577 0.0240
714 KNEE ARTHROPLASTY 504 0.0239
715 THERAPEUTIC RESPONSE DECREASED 1440 0.0237
716 RESPIRATORY TRACT INFECTION 615 0.0236
717 HEAD DISCOMFORT 418 0.0236
718 BLOOD POTASSIUM INCREASED 383 0.0236
719 JAUNDICE 634 0.0235
720 HEMIPARESIS 397 0.0234
721 LYMPHOMA 362 0.0234
722 INFECTION 3364 0.0232
723 PHOTOSENSITIVITY REACTION 383 0.0232
724 CELLULITIS 1164 0.0231
725 HEPATOTOXICITY 514 0.0231
726 HYPERTHYROIDISM 334 0.0230
727 HYPERKALAEMIA 808 0.0230
728 BLOOD PRESSURE SYSTOLIC INCREASED 449 0.0230
729 HEART RATE DECREASED 805 0.0229
730 DRUG ERUPTION 406 0.0229
731 DRUG DISPENSING ERROR 350 0.0229
732 HEPATIC FAILURE 690 0.0229
733 CONTUSION 2195 0.0228
734 CHRONIC KIDNEY DISEASE 1723 0.0227
735 HYPOCALCAEMIA 429 0.0226
736 CARDIAC DISORDER 2115 0.0226
737 MIGRAINE 2157 0.0226
738 BLOOD GLUCOSE INCREASED 4239 0.0225
739 ASTHENIA 8421 0.0224
740 GASTROOESOPHAGEAL REFLUX DISEASE 1801 0.0224
741 EAR INFECTION 593 0.0223
742 BLISTER 1251 0.0223
743 CARDIAC FAILURE 1788 0.0223
744 HYPOAESTHESIA 3300 0.0220
745 UNEVALUABLE EVENT 1666 0.0220
746 RASH MACULO-PAPULAR 486 0.0218
747 END STAGE RENAL DISEASE 398 0.0218
748 DISSEMINATED INTRAVASCULAR COAGULATION 307 0.0218
749 STAPHYLOCOCCAL INFECTION 717 0.0217
750 PLEURAL EFFUSION 1321 0.0217
751 RENAL IMPAIRMENT 1820 0.0216
752 ISCHAEMIC STROKE 386 0.0216
753 SUBDURAL HAEMATOMA 308 0.0215
754 ABDOMINAL PAIN 4965 0.0213
755 CEREBRAL INFARCTION 521 0.0213
756 MUSCLE SPASMS 3912 0.0213
757 INTENTIONAL PRODUCT USE ISSUE 1866 0.0213
758 FOOT FRACTURE 403 0.0212
759 ANGINA PECTORIS 608 0.0212
760 GASTRITIS 557 0.0211
761 TINNITUS 967 0.0210
762 OSTEOPOROSIS 863 0.0210
763 FEELING COLD 584 0.0210
764 ABASIA 516 0.0209
765 DISEASE RECURRENCE 993 0.0209
766 SWELLING 1948 0.0208
767 INFLAMMATION 1067 0.0207
768 VIRAL INFECTION 684 0.0205
769 HIP FRACTURE 658 0.0204
770 ASTHMA 2302 0.0203
771 UPPER RESPIRATORY TRACT INFECTION 938 0.0203
772 PRODUCT DISPENSING ERROR 439 0.0201
773 THERAPEUTIC RESPONSE UNEXPECTED 901 0.0201
774 GASTROINTESTINAL DISORDER 1799 0.0201
775 FATIGUE 15585 0.0200
776 UNDERDOSE 1455 0.0199
777 HAEMATOMA 508 0.0196
778 TUBULOINTERSTITIAL NEPHRITIS 366 0.0195
779 COAGULOPATHY 325 0.0195
780 PRODUCT SUBSTITUTION ISSUE 1119 0.0194
781 HYPOAESTHESIA ORAL 292 0.0194
782 STOMATITIS 1171 0.0193
783 DRUG INEFFECTIVE 25333 0.0192
784 RETCHING 409 0.0192
785 MULTI-ORGAN FAILURE 329 0.0190
786 ACUTE MYOCARDIAL INFARCTION 560 0.0190
787 ILL-DEFINED DISORDER 1153 0.0190
788 MUSCULOSKELETAL PAIN 993 0.0189
789 BLOOD PRESSURE INCREASED 2897 0.0189
790 ABDOMINAL DISTENSION 1976 0.0189
791 BLOOD URINE PRESENT 358 0.0188
792 NAUSEA 14904 0.0188
793 CARDIOVASCULAR DISORDER 477 0.0188
794 UPPER GASTROINTESTINAL HAEMORRHAGE 316 0.0188
795 ABSCESS 299 0.0187
796 MUSCULOSKELETAL CHEST PAIN 290 0.0187
797 PRODUCT PRESCRIBING ISSUE 408 0.0187
798 DRUG ADMINISTRATION ERROR 573 0.0187
799 FEELING HOT 1141 0.0186
800 TOOTHACHE 336 0.0185
801 BLOOD PRESSURE ABNORMAL 369 0.0185
802 IMMUNODEFICIENCY 274 0.0184
803 ABDOMINAL DISCOMFORT 3080 0.0183
804 JOINT INJURY 389 0.0182
805 DYSPEPSIA 1787 0.0181
806 NECK PAIN 1012 0.0181
807 VISUAL IMPAIRMENT 2233 0.0180
808 DYSPNOEA 10148 0.0179
809 NEOPLASM MALIGNANT 1192 0.0178
810 OSTEOPENIA 271 0.0178
811 BRONCHITIS 1321 0.0178
812 INTERVERTEBRAL DISC PROTRUSION 387 0.0177
813 RECTAL HAEMORRHAGE 759 0.0176
814 INFUSION RELATED REACTION 1171 0.0176
815 MYOCARDIAL INFARCTION 3077 0.0176
816 CEREBROVASCULAR ACCIDENT 2984 0.0176
817 ULCER 280 0.0176
818 GASTROENTERITIS VIRAL 317 0.0175
819 TASTE DISORDER 355 0.0175
820 RENAL INJURY 515 0.0173
821 PARAESTHESIA 2722 0.0173
822 RENAL DISORDER 805 0.0173
823 HEADACHE 10810 0.0172
824 PERIPHERAL SWELLING 2656 0.0172
825 MELAENA 379 0.0172
826 ABDOMINAL PAIN UPPER 3541 0.0172
827 GASTRIC ULCER 323 0.0170
828 LYMPHADENOPATHY 598 0.0169
829 GALLBLADDER DISORDER 301 0.0168
830 INFLUENZA LIKE ILLNESS 1386 0.0168
831 EYE DISORDER 553 0.0168
832 LIMB DISCOMFORT 519 0.0168
833 HAEMORRHOIDS 326 0.0167
834 ALOPECIA 3275 0.0167
835 COVID-19 2921 0.0166
836 LIMB INJURY 451 0.0166
837 UPPER LIMB FRACTURE 329 0.0165
838 SWELLING FACE 1075 0.0165
839 INTERNATIONAL NORMALISED RATIO INCREASED 470 0.0165
840 CORONARY ARTERY DISEASE 499 0.0165
841 CLOSTRIDIUM DIFFICILE INFECTION 358 0.0164
842 MOUTH ULCERATION 344 0.0163
843 MYALGIA 2766 0.0163
844 DRUG DOSE OMISSION 2684 0.0162
845 LABORATORY TEST ABNORMAL 474 0.0160
846 BLINDNESS 654 0.0160
847 PULMONARY HYPERTENSION 334 0.0160
848 GLAUCOMA 308 0.0160
849 HAEMATURIA 547 0.0160
850 ATRIAL FIBRILLATION 1553 0.0159
851 OROPHARYNGEAL PAIN 1466 0.0158
852 THERAPEUTIC RESPONSE SHORTENED 525 0.0158
853 CYSTITIS 498 0.0156
854 CONJUNCTIVITIS 290 0.0156
855 MUCOSAL INFLAMMATION 409 0.0156
856 THROAT TIGHTNESS 422 0.0156
857 TOOTH LOSS 322 0.0155
858 KIDNEY INFECTION 304 0.0155
859 SURGERY 907 0.0155
860 HYPERSENSITIVITY 2866 0.0154
861 JOINT SWELLING 1861 0.0154
862 VISUAL ACUITY REDUCED 512 0.0154
863 PRODUCT DOSE OMISSION ISSUE 4531 0.0154
864 NEURALGIA 373 0.0153
865 CHILLS 1797 0.0153
866 INTENTIONAL DOSE OMISSION 433 0.0152
867 COLITIS 575 0.0152
868 POST PROCEDURAL COMPLICATION 291 0.0151
869 ANGIOEDEMA 670 0.0151
870 CEREBRAL HAEMORRHAGE 539 0.0150
871 NEUROPATHY PERIPHERAL 1427 0.0150
872 HAEMOPTYSIS 418 0.0150
873 SKIN LESION 410 0.0149
874 BACTERIAL INFECTION 278 0.0149
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1060 0.0149
876 BACK PAIN 3455 0.0149
877 RASH GENERALISED 385 0.0149
878 SINUSITIS 1518 0.0148
879 MENSTRUATION IRREGULAR 396 0.0148
880 FLUID RETENTION 751 0.0148
881 NASAL CONGESTION 867 0.0147
882 DIARRHOEA 9475 0.0147
883 ORAL PAIN 328 0.0146
884 PAIN 8991 0.0146
885 MENORRHAGIA 286 0.0145
886 DRUG EFFECT DECREASED 781 0.0145
887 ILLNESS 1478 0.0143
888 PRODUCTIVE COUGH 681 0.0143
889 PERITONITIS 295 0.0142
890 DYSPHONIA 831 0.0142
891 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2851 0.0141
892 FREQUENT BOWEL MOVEMENTS 380 0.0141
893 LIP SWELLING 468 0.0140
894 EPISTAXIS 1046 0.0140
895 PNEUMONITIS 378 0.0139
896 PAIN IN JAW 392 0.0138
897 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2493 0.0138
898 SKIN DISCOLOURATION 635 0.0138
899 CARDIAC FAILURE CONGESTIVE 1107 0.0138
900 SPINAL FRACTURE 276 0.0138
901 RHEUMATOID ARTHRITIS 1561 0.0137
902 RASH 5979 0.0137
903 GASTROINTESTINAL HAEMORRHAGE 1146 0.0137
904 PRODUCT DOSE OMISSION 895 0.0137
905 INFLUENZA 1527 0.0137
906 BURNING SENSATION 960 0.0137
907 PAIN IN EXTREMITY 4025 0.0136
908 NO ADVERSE EVENT 2457 0.0135
909 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 396 0.0135
910 CHEST DISCOMFORT 1383 0.0135
911 NASOPHARYNGITIS 2488 0.0135
912 TOOTH DISORDER 300 0.0135
913 BONE MARROW FAILURE 274 0.0135
914 DRUG EFFECT INCOMPLETE 488 0.0134
915 INCORRECT DOSE ADMINISTERED 3040 0.0133
916 SKIN DISORDER 443 0.0133
917 CYTOKINE RELEASE SYNDROME 266 0.0132
918 RHINORRHOEA 852 0.0132
919 HAEMATOCHEZIA 727 0.0132
920 NEPHROLITHIASIS 603 0.0131
921 CHROMATURIA 296 0.0131
922 ASCITES 384 0.0130
923 RASH ERYTHEMATOUS 601 0.0126
924 DRUG DEPENDENCE 2019 0.0125
925 SKIN ULCER 323 0.0125
926 EYE PAIN 699 0.0124
927 BLOOD GLUCOSE DECREASED 593 0.0123
928 LOCALISED INFECTION 297 0.0123
929 COUGH 3438 0.0122
930 ARTHRITIS 961 0.0122
931 THROMBOSIS 975 0.0121
932 URTICARIA 2028 0.0121
933 GASTRIC DISORDER 403 0.0117
934 PRODUCT DOSE OMISSION IN ERROR 330 0.0116
935 FLATULENCE 656 0.0116
936 ARTHRALGIA 4800 0.0115
937 DRY EYE 576 0.0115
938 CATARACT 686 0.0115
939 FEMUR FRACTURE 354 0.0114
940 INTERSTITIAL LUNG DISEASE 553 0.0114
941 DEAFNESS 295 0.0113
942 EYE SWELLING 416 0.0112
943 DYSPNOEA EXERTIONAL 420 0.0111
944 ABDOMINAL PAIN LOWER 280 0.0111
945 RASH PRURITIC 586 0.0108
946 FUNGAL INFECTION 349 0.0105
947 ANAPHYLACTIC REACTION 567 0.0103
948 MULTIPLE SCLEROSIS 483 0.0101
949 HAEMORRHAGE 1050 0.0100
950 PRURITUS 3846 0.0100
951 VAGINAL HAEMORRHAGE 427 0.0098
952 COLITIS ULCERATIVE 438 0.0098
953 NEEDLE ISSUE 277 0.0095
954 HOT FLUSH 717 0.0095
955 HYPOACUSIS 404 0.0094
956 LACRIMATION INCREASED 273 0.0090
957 DYSGEUSIA 670 0.0090
958 RASH MACULAR 313 0.0089
959 ERYTHEMA 1818 0.0088
960 FLUSHING 899 0.0088
961 BONE PAIN 518 0.0088
962 DEVICE DISLOCATION 381 0.0088
963 ECZEMA 456 0.0087
964 PLASMA CELL MYELOMA 333 0.0085
965 EXTRA DOSE ADMINISTERED 334 0.0082
966 OCULAR HYPERAEMIA 391 0.0082
967 PRODUCT QUALITY ISSUE 1111 0.0082
968 THROAT IRRITATION 360 0.0080
969 DISEASE PROGRESSION 939 0.0079
970 ACNE 596 0.0079
971 INJECTION SITE MASS 290 0.0078
972 PSORIASIS 1014 0.0078
973 INCORRECT ROUTE OF DRUG ADMINISTRATION 275 0.0077
974 BREAST CANCER 700 0.0075
975 MULTIPLE SCLEROSIS RELAPSE 501 0.0073
976 HERPES ZOSTER 407 0.0071
977 SKIN EXFOLIATION 595 0.0070
978 DEPENDENCE 373 0.0068
979 DEVICE ISSUE 599 0.0067
980 DRY SKIN 880 0.0066
981 DEVICE LEAKAGE 262 0.0060
982 EYE IRRITATION 325 0.0056
983 SKIN BURNING SENSATION 381 0.0053
984 DERMATITIS ATOPIC 268 0.0051
985 MALIGNANT NEOPLASM PROGRESSION 505 0.0049
986 ACCIDENTAL EXPOSURE TO PRODUCT 498 0.0048
987 INJECTION SITE REACTION 326 0.0047
988 INJECTION SITE PAIN 1336 0.0044
989 INJECTION SITE SWELLING 309 0.0040
990 DEVICE MALFUNCTION 264 0.0038
991 INJECTION SITE ERYTHEMA 384 0.0031